Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” terminology is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T06:24:56.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0. The study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T06:29:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.
    Difference
    1%
    Check dated 2026-10-25T06:52:06.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T06:53:23.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T08:51:06.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual content with an access-restricted notice. The additions include the 403 text and typical site header/footer indicating the page is blocked.
    Difference
    22%
    Check dated 2026-09-20T03:50:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.